Skip to main content
    P

    PACS Group, Inc. (PACS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $49.04
    +0.72 (+1.49%)

    Market Cap: $7.67B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    PACS Group, Inc. (PACS) Earnings: Report Dates and Results

    Updated Nov 3, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    PACS Group (PACS) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, PACS Group reported EPS of $0.63, above the $0.56 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    73%(8/11)
    Avg Surprise
    +12.40%
    Streak
    3 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.67
    Range$0.62 - $0.75
    8 analysts
    Revenue Consensus
    $1.71B
    Range$1.62B - $1.79B
    8 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus$0.69
    Range$0.66 - $0.70
    3 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.70-1.4%
    60d ago$0.70-1.4%
    30d ago$0.68+0.9%
    7d ago$0.66+4.0%
    Current$0.69
    Revenue Consensus
    $1.75B
    Range$1.70B - $1.79B
    3 analysts

    Next Report

    PACS has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 55.8% above the $0.43 reported for the quarter ended Dec 31, 2025.

    PACS Earnings Call

    The latest PACS earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Earnings History

    Of the 11 quarters below that had an estimate, PACS beat 8 and missed 3. Revenue for the quarter ended Sep 30, 2026 was $1.50B, up 11.9% from $1.34B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.63$0.56$0.55 - $0.64+12.50%Beat+40.0%53 up, 0 downNov 3, 2026$1.50B
    Jun 30, 2026$0.63$0.55$0.52 - $0.60+14.55%Beat+40.0%42 up, 0 downAug 4, 2026$1.43B
    Mar 31, 2026$0.64$0.41$0.38 - $0.43+56.10%Beat+52.4%43 up, 0 downMay 11, 2026$1.42B
    Dec 31, 2025$0.43$0.48N/A-10.42%Miss+9.9%N/AN/AFeb 26, 2026$1.36B
    Sep 30, 2025$0.45$0.47N/A-4.26%Miss+32.4%N/AN/ANov 19, 2025$1.34B
    Jun 30, 2025$0.45$0.48N/A-6.25%Miss-6.2%N/AN/AAug 18, 2025$1.31B
    Mar 31, 2025$0.42$0.40N/A+5.00%Beat+23.5%N/AN/ASep 11, 2025$1.28B
    Dec 31, 2024$0.39$0.35N/A+11.74%BeatN/A10 up, 0 downFeb 26, 2025$1.21B
    Sep 30, 2024$0.34$0.33$0.33 - $0.33+3.03%BeatN/A10 up, 0 downNov 8, 2024$1.03B
    Jun 30, 2024$0.48$0.35N/A+37.14%BeatN/AN/AN/AAug 12, 2024$935.71M
    Mar 31, 2024$0.34$0.29N/A+17.24%BeatN/AN/AN/AMay 13, 2024$919.84M
    Last 11 quarters

    Annual EPS

    Fiscal year endedEPSChange
    Sep 30, 2026$1.90+49.6%
    Jun 30, 2026$1.27-27.4%
    Dec 31, 2025$1.75+12.8%
    Dec 31, 2024$1.55+474.5%
    Jun 30, 2024$0.27N/A

    Earnings Calls

    The 4 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 7,000 words across 10 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q2Jun 30, 20266,98410
    2026Q1Mar 31, 20266,95411
    2025Q4Dec 31, 20255,2986
    2025Q3Sep 30, 20255,7277

    2026Q2 Earnings Call

    Opening remarks

    Ryan Welch Director of Corporate Finance Thank you, and good morning, everyone. Thank you for joining us for our earnings call. Before we begin the prepared remarks, we would like to remind you that yesterday, PACS Group issued a press release announcing its second quarter 2026 results. An investor presentation was published and is available on the Investor Relations section of pacs.com. I'd also like to remind everyone that during the course of today's conference call, we will discuss certain forward-looking information, including our expectations for 2026 revenue and adjusted EBITDA that is based on our current expectations, assumptions and beliefs about our business. Any forward-looking statements are subject to risks and uncertainties that could cause our actual results to materially differ from those expressed or implied on today's call. You should carefully consider the risk factors that may affect our future results as described in our annual report on Form 10-K for the year ended December 31, 2025, and our other SEC filings. During this call, we will discuss certain non-GAAP financial measures, including adjusted net income, adjusted earnings per share, adjusted EBITDA, adjusted EBITDAR and net leverage. These non-GAAP financial measures should be considered as a supplement to and not a substitute for measures prepared in accordance with GAAP. For a reconciliation of non-GAAP financial measures discussed during this call to the most directly comparable GAAP measure, please refer to the earnings release and the appendix included in the investor presentation, which are both published and available on the Investor Relations section of PACS Group's website. I'll now turn the call over to Jason Murray, Chairman and CEO.

    Jason Murray Chairman and Chief Executive Officer Thanks, Ryan, and thanks, everyone, for joining us this morning. We're pleased to report another strong quarter for PACS and to close out the first half of 2026 with continued momentum across the organization. Building on the strong start we delivered in the first quarter, our second quarter results reflect the sustainability of our operating model, the continued execution of our teams and the meaningful progress we're seeing across facilities at every stage of our maturity cohorts. Throughout the first half of the year, our teams remained focused on strengthening performance across the existing portfolio, advancing recently acquired facilities toward mature operating levels and continuing to invest in the people and infrastructure required to support our growth. That focus is showing up in our results. Our existing portfolio continues to perform very well. Quality outcomes are improving, and the strength of our leadership bench and balance sheet is allowing us to pursue the next phase of growth from a position of strength. Revenue increased 9.1% in the second quarter, while adjusted EBITDA grew 25% compared to the prior year.

    Frequently Asked Questions About PACS

    When is PACS Group's next earnings date?

    PACS Group's next earnings report is expected for Feb 24, 2027.

    Did PACS beat earnings estimates last quarter?

    Yes. PACS Group reported EPS of $0.63 for the quarter ended Sep 30, 2026, above the $0.56 estimate, a 12.50% surprise.

    What EPS do analysts expect from PACS next quarter?

    The consensus EPS estimate for PACS Group for the quarter ending Dec 31, 2026 is $0.67 from 8 analysts, with estimates from $0.62 to $0.75.

    How often does PACS beat earnings estimates?

    PACS Group beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +9.87%.